T1	intervention 22 33	salidroside
T2	condition 37 108	epirubicin-induced early left ventricular regional systolic dysfunction
T3	No-of-participants 856 861	Sixty
T4	intervention-participants 1004 1006	30
T5	control 1011 1018	placebo
T6	control-participants 1024 1026	30
T7	outcome-Measure 1168 1222	plasma concentrations of reactive oxygen species (ROS)
T8	outcome-Measure 1104 1120	echocardiography
T9	outcome-Measure 1125 1149	strain rate (SR) imaging
T10	outcome 1323 1345	decline of the SR peak
T11	outcome 1816 1837	plasma concentrations
